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Technical Report
Abstract
Purpose: Intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) has the capacity to optimize
the dose distribution. We analyzed the dosimetric differences of plans in treatment planning system (TPS) between VMAT and
IMRT in treating breast cancer. Methods: Fourteen patients were simulated, planned, and treated with VMAT using single,
double or partial arcs. IMRT treatments were generated using 4 to 5 tangential IMRT fields for the same patients. All treatment
plans were planned for 50 Gy in 25 fractions. The VMAT and IMRT plans were compared using the planning target volume
(PTV) dose and doses to the other organs at risk (OARs). Results: For the PTV, comparable minimum, mean, maximum, median,
and modal dose as well equivalent sphere diameter of the structure (Equis) were observed between VMAT and IMRT plans and
found that these values were significantly equal in both techniques. The right lung mean and modal doses were considerably
higher in VMAT plans while maximum value was considerably lower when compared with IMRT plans. The left lung mean and
modal doses were higher with VMAT while maximum doses were higher in IMRT plans. The mean dose to the heart and
maximum dose to the spinal cord was lower with IMRT. The mean dose to the body was higher in VMAT plans while the
maximum dose was higher in IMRT plans. Conclusion: Four field tangential IMRT delivered comparable PTV dose with gener-
ally less dose to normal tissues in our breast cancer treatment study. The IMRT plans typically had more favourable dose char-
acteristics to the lung, heart, and spinal cord and body dose when compared with VMAT. The only minor advantage of VMAT for
breast cases was slightly better PTV coverage.
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Introduction
The number of patients with breast cancer treated with radi-
ation therapy has increased in the past few years. Normal
tissue toxicities can limit the advantage of this treatment
modality.1-2 Standard tangential beams have resulted in ex-
cellent local control rates, low rates of cardiac and pulmonary
complications, and excellent cosmetic results in the vast ma-
jority of patients.3-7 Three-dimensional conformal radio-
therapy (3D-CRT) and intensity-modulated radiotherapy
(IMRT) techniques improve the treatment delivery by im-
proving the target volume coverage and minimizing dose to
other organs at risk (OARs).8-18 With IMRT, it is possible to
reduce the volume of the lung irradiated to full doses by
tangential fields, and in left-sided cases, the heart can also be
partially spared. Several publications on this topic have dis-
cussed advantages and disadvantages of IMRT versus volu-
metric modulated arc therapy (VMAT).19-21
The use of RapidArc or VMAT (Novalis Tx, Varian Medical
Systems, Inc, Palo Alto, USA) is receiving increased attention
as an advanced technique in radiotherapy for fast delivery
treatment with improved dose distribution. In an effort to
identify and characterize dosimetric differences between
VMAT and IMRT techniques for the breast cancer, we ana-
lyzed the calculated dose characteristics of VMAT and simu-
lated treatment plans of IMRT in 14 breast cancer patients.
For the purpose of this analysis, we assumed similar mean
dose within target produces similar tumor control with these
two techniques.
Methods and Materials
Fourteen patients presented with breast cancer (eight left side
and six right side). Twelve of these cases were intact breast
and two cases were post mastectomy. Each patient was im-
mobilized using full body Vaclok (IBA, Bahnhofstrasse,
Schwarzenbruck, Germany) for simulation and subsequent
treatment. Axial computed tomography (CT) images of 5 mm
thickness were obtained on a Philips Brilliance big bore
16-slice CT simulator (Philips Health Care, DA Best, Neth-
erlands). The data was then exported to the Eclipse work-
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station (Eclipse treatment planning system (TPS), version 8.6;
Varian Medical Systems, Palo Alto, CA, USA) where normal
tissue and tumor segmentation were performed through the
use of the available contouring tools. The gross tumor volume
(GTV) was defined using soft tissue window. The planning
target volume (PTV) was created by a 0.5 cm axial and 1.0 cm
longitudinal expansion of the GTV. The OARs including
lungs, heart, and spinal cord were contoured.
The VMAT treatment plans were designed using partial,
single or paired arcs in the Eclipse TPS to achieve optimal
PTV coverage and minimal OAR dose. High definition mul-
tileaf collimation was optimized using beams-eye-view for
each arc of every patient’s plan. The plans were then nor-
malized to 100% of the dose to the mean of the PTV. The
prescription dose was 50 Gy in 25 fractions for all plans. The
constraints for the OARs included maximum dose of 35 Gy,
30Gy, and 25 Gy to spinal cord, heart, and lung, respectively.
The VMAT treatments were planned using the analytic ani-
sotropic algorithm (AAA), Modified Batho algorithm for
tissue heterogeneity corrections and AAA field volume dose
algorithm for ARC calculations. Partial ARC, full ARC, and
dual ARCs were used for planning to yield the best target
coverage possible.
For comparative analysis, simulated treatment plans using 4
to 5 tangential intensity modulated beams were generated in
Eclipse TPS. The same PTV and OAR structures as those
defined at the time of VMAT treatment were used for the
IMRT planning. Beams were manually selected to maximize
access to the target while minimizing exposure to adjacent
normal tissues. All the plans were optimized to allow for 95%
coverage of PTV. Calculated dose characteristics to the PTV,
spinal cord, lungs, and heart were compared. A two-tailed
paired t-test was used to compare the VMAT and IMRT
techniques in respect of dose to target and normal structures
with a significance declared for a p < 0.05 (Table 1). Addi-
tionally, both the VMAT and IMRT plans were normalized to
200 cGy at isocenter for the QA purpose. Patient specific QA
was done using 0.1 cc ionization chamber in a small cylin-
drical phantom.
Results
The IMRT plans demonstrated significantly lower mean doses
to OARs and equivalent doses to the PTV when compared
with VMAT plans. Representative dose distributions between
VMAT treatment plans and IMRT plans are presented in
(Figure 1) and dose volume histograms are shown in (Figure
2).
FIG. 1: An example of dose distribution between VMAT and IMRT breast cancer treatment plans
FIG. 2: An example of cumulative dose-volume histogram (DVH) of VMAT and IMRT plans for breast cancer.
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The IMRT plans exhibited equal minimum and mean doses
for the PTV when compared to the VMAT plans. In compar-
ison between the two plans, the PTV maximum doses were
higher with in the IMRT plans than in the VMAT plans
(Figure 3). Table 1 shows that the mean and median doses to
the right lung were significantly lower with IMRT, whereas
the maximum dose was significantly lower with VMAT.
IMRT delivery comparisons between two IMRT delivery
techniques for QA plans are shown in Table 2. There is a
significant difference in the mean values of dose range be-
tween IMRT and VMAT in case of lungs. The minimum and
mean doses were higher in VMAT for the heart and spinal
cord. While the heart maximum and spinal cord maximum
doses are lower. The IMRT plan yields a significantly lower
mean and median dose to the body (Table 1). For the VMAT,
the Standard Deviation in Percentage (STD %) is lower for
the OARs and higher for the PTV with the exception of spinal
cord. The maximum dose is higher in IMRT for all organs
including the PTV. Equis is observed to be same for both
techniques for target and the OARs. On average, the treat-
ment MUs were 67% less with VMAT compared with IMRT
for the selected 14 patients in this study (Table 3).
Discussion
The VMAT technology is the most recent innovative tech-
nology in conventional photon therapy and widely used
treatment technique in the entire world. As the treatment
time, beam on time, and the number of monitor units (MUs)
are less compared with IMRT, more hospitals prefer VMAT
compared to other treatment techniques in photon therapy.
The results provided in our study provide evidence that
IMRT treatments can be developed that provide target cov-
erage as VMAT.
According to Ashraf et al.22, the conformity to the PTV and
critical structure sparing was better with 3DCRT than IMRT.
In contrast to the Ashraf et al.22, Moorthy et al.23 published
that, with the use of IMRT technique, there was an im-
provement in CI when compared to CI of 3DCRT. The study
conducted by Popescu et al.24 concluded that VMAT achieved
similar PTV coverage and sparing of OARs, with fewer MUs
and shorter delivery time than conventional IMRT. Accord-
ing to their study 24, the healthy tissue volume percentages
receiving 5 Gy were significantly larger with VMAT (33.1% ±
2.1%) and IMRT (45.3% ± 3.1%) than with conventional
modified wide-tangent technique (19.4% ± 3.7%). According
to study conducted by Johansen et al.25, a better homogeneity
and conformation in PTV was observed in the VMAT plans.
The highest minimum dose to PTV was observed in the
conventional plans while no difference was observed for
minimum significant doses D (98%) and D (99%) where D
(X%) is the dose received by X% of the PTV volume. In terms
of OAR sparing, the IMRT and RapidArc plans spare ipsilat-
eral-lung better, but a 40% lower mean dose in the con-
tra-lateral lung in the conventional plans is observed. The
mean dose to the contra-lateral breast was lowest for the
RapidArc plans as well as the V (10Gy) and the maximum
dose.
RapidArc, however, is capable of producing better plans than
IMRT for the test cases examined by Oliver et al.26 According
to them, the conformity of dose distribution to target is better
in RapidArc compared with IMRT. But integral dose is more
in tomotherapy compared to RapidArc and IMRT. According
to Nicolini et al.27, RapidArc showed dosimetric improve-
ments with respect to IMRT. But they also have mentioned
that mean dose to heart was 6.0 ± 2.7 Gy (RapidArc) and 7.4 ±
2.5 Gy (IMRT). We have also reported similar result in this
study. We have demonstrated the pros and cons of the VMAT
technique for breast cancer plans instead of just highlighting
the only positive aspects of the VMAT.
FIG. 3: Minimum, mean and maximum dose to PTV in VMAT and IMRT.
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TABLE 1: Dose calculations to PTV, body and normal structures with VMAT and tangential four field IMRT. The results are averaged over
fourteen breast cancer cases in this study.
[100% = prescribed dose; dose statistics obtained from the Eclipse TPS]
VMAT (RapidArc) IMRT
Median Range p -value Median Range p-value
PTV Dose coverage (%) 100 0 0.0001 100 0.4 0.0001
Min value (%) 63.3 68.7 0.0001 58.6 62.5 0.0001
Max value (%) 111 12.5 0.0001 114.7 20.8 0.0001
Mean value (%) 100 0 0.0001 100 3.5 0.0001
Modal D value (%) 101.1 5.8 0.0001 101 5.2 0.0001
Median (%) 100.6 1.2 0.0001 100.4 4.3 0.0001
STD (%) 4.6 3.5 0.0001 3.9 11 0.0001
Equis (%) 12.9 7 0.0001 12.9 7 0.0001
RT lung Dose coverage (%) 100 0 0.0001 100 0 0.0001
Min value (%) 2.8 21.1 0.0026 0.6 4 0.0038
Max value (%) 73.1 83.7 0.0001 93.7 103.9 0.0001
Mean value (%) 18.7 59.7 0.0021 10.1 56.4 0.0021
Modal D value (%) 14.9 86 0.0023 1.4 86 0.1324
Median (%) 18.5 60.7 0.0001 9.4 63.9 0.0068
STD (%) 7 23.8 0.0001 7.9 32.4 0.0004
Equis (%) 12.4 1.8 0.0001 12.4 1.8 0.0001
LT Lung Dose coverage (%) 100 0 0.0001 100 0 0.0001
Min value (%) 2.5 15.6 0.0009 0.8 5.3 0.007
Max value (%) 100.7 90 0.0001 102.5 90 0.0001
Mean value (%) 48.1 49.6 0.0001 31.2 47.8 0.0003
Modal D value (%) 21.9 93 0.0004 1.7 36.7 0.0522
Median (%) 43.2 53.9 0.0001 7.8 43.7 0.0034
STD (%) 24.7 26.7 0.0001 28.9 38.4 0.0001
Equis (%) 11.5 2 0.0001 11.5 2 0.0001
Heart Dose coverage (%) 100 0 0.0001 100 0 0.0001
Min value (%) 7.7 17.2 0.0001 1.7 7.5 0.0006
Max value (%) 101.1 29.4 0.0001 101.6 75.1 0.0001
Mean value (%) 35.5 33 0.0001 25 41.6 0.0001
Modal D value (%) 23.5 37.9 0.0001 2.5 32.7 0.0156
Median (%) 31.4 39.3 0.0001 13.1 34.7 0.0001
STD (%) 18.8 16.1 0.0001 22.5 32.7 0.0001
Equis (%) 9.6 3 0.0001 9.6 3 0.0001
SC Dose coverage (%) 100 0 0.0001 100 28.4 0.0001
Min value (%) 0.7 18.4 0.0763 0.4 7.8 0.0658
Max value (%) 11.6 77.8 0.0001 13.3 101 0.0035
Mean value (%) 14.5 45.1 0.0001 2.4 43.4 0.0364
Modal D value (%) 0.8 37.5 0.1176 1 18 0.0846
Median (%) 15.1 41.5 0.0001 1.9 30.1 0.0389
STD (%) 10.7 15.3 0.0001 1.1 29.3 0.0214
Equis (%) 4.3 6.3 0.0001 4.3 6.3 0.0001
BODY Dose coverage (%) 100 0 0.0001 96 33.9 0.0001
Min value (%) 0 0.1 0.3343 0 0 0.0001
Max value (%) 111.8 12.5 0.0001 120.9 19.3 0.0001
Mean value (%) 18.5 14 0.0001 15.2 17.5 0.0001
Modal D value (%) 0.6 1.7 0.0008 0.2 0.8 0.0028
Median (%) 6.4 9.1 0.0001 1.2 4.6 0.0002
STD (%) 27.3 10.9 0.0002 30.3 12.4 0.0001
Equis (%) 34.4 8.3 0.0001 34.4 8.3 0.0001
Dose coverage (%) = percentage of the structure volume covered by the dose matrix, which is a three dimensional matrix with in which the dose
distribution is calculated; p-value (typically ≤ 0.05) indicates strong evidence against the null hypothesis.
With the current beam arrangements calculations, it is reasonable to conclude that all of the analyzed IMRT approaches generally
deliver fewer doses to adjacent normal tissues compared with VMAT without compromising target coverage. It was observed that
a relatively larger volume of lung received a minimum dose and the prescribed dose limits with IMRT compared with VMAT.
The absolute differences between mean doses were quite large approximately 17.5 Gy to 22 Gy. Body dose is more in VMAT
when compared with IMRT treatments.
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TABLE 2: Comparisons between IMRT and VMAT delivery techniques.
Patient
#
Dose in TPS at
isocenter ( cGy)
Dose with chamber
in IMRT ( cGy)
Dose with chamber in
VMAT (cGy)
% Variation Between
VMAT and IMRT
1 200 199 195 2
2 200 197 203 2.9
3 200 200 199 0.5
4 200 198 200 1
5 200 205 206 0.4
6 200 203 195 3.9
7 200 201 195 2.9
8 200 201 201 0
9 200 202 205 1.5
10 200 203 205 1.5
11 200 200 195 2.5
12 200 201 202 0.5
13 200 203 205 1.5
14 200 198 201 1.5
TABLE 3: Monitor units (MUs) comparisons between IMRT and VMAT techniques.
Patient
#
IMRT
(MU)
VMAT
(MU)
% of variation between
VMAT and IMRT (MU)
1 2024 594 70
2 420 240 43
3 1236 417 66
4 1334 283 79
5 1135 502 56
6 1050 181 83
7 680 492 28
8 2826 342 88
9 1590 473 70
10 1389 350 75
11 1402 467 67
12 1560 483 69
13 1227 495 60
14 2180 318 85
Conclusion
IMRT plans with four to five tangential beams provide com-
parable coverage of the PTV relative to VMAT plans in breast
cancer. Typically comparable coverage was achieved by
IMRT with less dose to adjacent normal tissue and integral
dose. VMAT technique produced relatively larger volumes of
lung, heart, and spinal cord exposed to the radiation.
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